CALL FOR PAPERS Physiology and Pharmacology of Temperature Regulation Central angiotensin AT1-receptor blockade affects thermoregulation and running performance in rats

Leite, Laura H. R., Ana Cristina R. Lacerda, Umeko Marubayashi, and Cândido C. Coimbra. Central angiotensin AT1-receptor blockade affects thermoregulation and running performance in rats. Am J Physiol Regul Integr Comp Physiol 291: R603–R607, 2006. First published April 13, 2006; doi:10.1152/ajpregu.00038.2006.— The effect of central angiotensin AT1-receptor blockade on thermoregulation in rats during exercise on a treadmill (18 m/min, 5% inclination) was investigated. Core (Tb) and skin tail temperatures were measured in rats while they were exercising until fatigue after injection of 2 l of losartan (Los; 20 nmol, n 4; 30 nmol, n 4; 60 nmol, n 7), an angiotensin II AT1-receptor antagonist, or 2 l of 0.15 mol/l NaCl (Sal; n 15) into the right lateral cerebral ventricle. Body heat rate (BHR), heat storage rate, threshold Tb for tail vasodilation (TTbV), time to fatigue, and workload were calculated. During exercise, the BHR and heat storage rate of Los-treated animals were, respectively, 40 and 53% higher (P 0.01) than in Sal-treated animals. Additionally, rats injected with Los showed an increased TTbV (38.59 0.19°C for Los vs. 38.12 0.1°C for Sal, P 0.02), a higher Tb at fatigue point (39.07 0.14°C Los vs. 38.66 0.07°C Sal, P 0.01), and a reduced running performance (27.29 4.48 min Los vs. 52.47 6.67 min Sal, P 0.01), which was closely related to the increased BHR. Our data suggest that AT1-receptor blockade attenuates heat dissipation during exercise due to the higher TTbV, leading to a faster exercise-induced increase in Tb, thus decreasing running performance.